Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

Adherence and Outcome of Upper Airway Stimulation (UAS) for OSA International Registry

← catalyst calendar

NCT02907398

Sponsored by Inspire Medical Systems, Inc. (industry) · INSP — their whole pipeline →.

Phase
Status
Unknown status
Study type
Observational
Enrollment
5,000actual
Sites
64
Countries
Belgium, Germany, Netherlands +2

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2016-10-19actualWhen the study began enrolling
Primary completionSep 2025estimatedThe date the last participant is measured for the primary outcome — the readout window
Study completionDec 2025estimatedThe whole study's end, after follow-up
First posted2016-09-20estimatedWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2025-06-19actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Condition

  • Obstructive Sleep Apnea

Interventions

  • Device: Inspire therapy — also filed as ADHERE
  • Other: No intervention — also filed as CONTROL

Primary outcomes

what the primary-completion date above is the date OF
Change in Apnea Hypopnea (AHI) from Baseline to 12-Months
measured Baseline through 12 months
Change in Epworth Sleepiness Scale (ESS) from Baseline to 12 Months
measured Baseline through 12 months

Publications

Linked on the registry record. A “linked by the registry” entry is NLM's own automated PubMed match, not a claim by the sponsor that the paper reports this study.

Permalink · INSP's whole pipeline · Catalyst calendar · Every registered study · What changed